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Abstract
On average, each Ventilator-Associated Event (VAE) is anticipated to increase the length
of stay in the Intensive Care Unit (ICU), resulting in potential adverse events and cost to the
organization. The Center for Disease Control (CDC) defines VAE as the increase of daily
minimum positive end-expiratory pressure (PEEP) and fraction of inspired oxygen (FiO2)
values, after a baseline period of patient stability or improvement on the ventilator (CDC, 2018).
Standard endotracheal tube designs have led to the incidence of VAE because of the
accumulation of subglottic secretions in the trachea. Untreated VAE can later result in Ventilator
Associated Pneumonia (VAP). A clinical nurse leader (CNL) focuses on all clinical elements to
reduce subglottic secretions by leading a practice improvement project in the Level II Trauma
Center of a mid-sized suburban community hospital with assistance of a multidisciplinary team
called Prevent VAE Team. The multidisciplinary team will assess the incidence of VAE and aim
to evaluate interventions that increase adherence to evidence-based practices to reduce VAP. A
retrospective case review reveals that the pattern and prevalence of VAE is primarily related to
the presence of the standard endotracheal tube, which causes accumulation of subglottic
secretions in the trachea, on patients hospitalized in the ICU setting. Based on the observed
variation in the ICU microsystem, placing subglottic endotracheal tubes (SETT) into the
operating room (OR) and emergency medical system (EMS) settings appears to address the root
cause of excessive VAE in the ICU setting. Providing front line staff feedback, debriefing, and
coaching brought awareness to achieve the long-term goal of reducing VAE to zero. Over a 6month period, this improvement project resulted in reduction of VAE from 31 ICU events (six
attributed to trauma patients) to three ICU events (0 attributed to trauma patients). The
improvement project supports the creation of a culture of safety, continuous improvement,
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evidence-based practice, and cost avoidance in the ICU. The organizational commitment to this
project will extend over a 1-year period.
Keywords: Ventilator-Associated Event, Intensive Care Unit, positive end-expiratory
pressure, fraction of inspired oxygen, Ventilator Associated Pneumonia, Ventilator Associated
Pneumonia, subglottic endotracheal tube.
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Introduction
Increased mortality projections have been associated with increase Intensive Care
Unit (ICU) length of stay (Bekaert, 2011). The problem is that on average, a diagnosis
including ventilator-associated event (VAE) is anticipated to increase ICU length of stay
by a mean of 4.3 days with a 95% confidence interval, 1.5 – 7.0 day: P<.001 (Vincent,
2012).
The Center for Disease Control (CDC) defines VAE as the increase of daily
minimum positive end-expiratory pressure (PEEP) and fraction of inspired oxygen (FiO2)
values, after a baseline period of patient stability or improvement on the ventilator for
over 48 hours (CDC, 2018). Daily min FiO2 has to increase >= 0.20 (20 points) for >=2
days. PEEP value is defined by a daily min PEEP increase >= 3 cm H2O maintained for
>=2 days (NHSN, 2017).
Untreated VAE can later result in Ventilator Associated Pneumonia (VAP). For a VAP to
occur, the VAE patient has to have a spike in temperature and increase of white blood cells
(WBC). Fever is defined as a body temperature of >100.4 ºF or >38 ºC. White blood cell
(WBC) is defined as increase of WBC >12,000 cells/mm³ or <4,000 cells/mm³. All
ventilated patients with early identification of pneumonia will start new antimicrobial
agent(s) and will continue the treatment for >= 4 days (NHSN, 2017). These
differentiation factors determine whether a patient has VAE or a VAP.
Standard endotracheal tube designs have led to the incidence of VAE because of
the accumulation of subglottic secretions in the trachea. With the accumulation of
secretions, the patient is at risk to develop a biofilm that will lead to the growth of
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microorganisms. Reduction of subglottic secretions will eliminate the bacterial -rich
environment, which generates VAP (Muscedere et al., 2011). The diagnosis of VAP is
normally seen in the electronic health record, so for the emphasis of this project will refer to
VAP as the acute diagnosis derived from adverse ventilator associated event (National Health
Safety Network [NHSN], 2017).
Available knowledge
In 2013, NHSN through a multidisciplinary collaborative integrated by Critical Care
Societies, American College of Chest Physicians, American Thoracic Society, American
Association for Respiratory Care, Association of Professionals in Infection Control and
Epidemiology, Council of State and Territorial Epidemiologists, Healthcare Infection Control
Practices Advisory Committee’s Surveillance Working Group, Infectious Diseases Society of
America, and Society for Healthcare Epidemiology of America, develop objective criteria for
determining VAE as a hospital-acquired infections (NHSN, 2017). The VAE Surveillance
Algorithm (Appendix A) objectively demonstrate a standardized measure to consistently define
VAE.
Over 300,000 patients per year in the United States will incur medical conditions that
warrant mechanical ventilation (Cason, Tyner, Saunders, & Broome, 2007). Ventilatorassociated events are preventable. As CNLs, it is our mission to improve patient outcomes by
ensuring the safe delivery of VAE prevention bundles. The goal of this quality improvement
project is to reduce subglottic secretions, which produce biofilm on the endotracheal tubes that
provide the bacterial-rich environment, which generates VAE.
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Problem description
With the accumulation of secretions, the patient is at risk to develop a biofilm that will
lead to the growth of microorganisms. Reduction of subglottic secretions will eliminate the
bacterial-rich environment, which generates VAP (Muscedere et al., 2011). During a prospective
meta-analyses cohort study with randomized controlled trials, a multicenter European study
shows VAE to be the most common Hospital Associated Condition (HAC) in the ICU, with a
mortality associated of 24% to 71%. The study shows that the most common causative
organisms are Staphylococcus aureus, Pseudomonas aeruginosa, and Enterobacteriaceae. These
organisms affect 9% to 24% of ventilated patients (Vincent, 2012).
The most costly HAC that affects the local Level II Trauma Center is VAE. The
incidence of VAE that drew the trauma department’s attention was that 21 VAE events has been
attributed to ventilated trauma patients in 2017. In the first six months of 2018, 6 events are
identified as HAC (CDM, 2018).
In a comprehensive microsystem assessment, VAE identification continues to be the
highest HAC incidence of the Trauma Quality Improvement Program’s (TQIP) report. Over the
last year, the incidence of VAE has increased to be the number one HAC in the Level II Trauma
Center’s ICU. From January to June 2018, there has been six VAE cases identified. Although the
number may not seem daunting, that increased mortality associated with VAE, is a stimulus for
action for the multidisciplinary team, called Prevent VAE Team (TQIP, 2018).
The 2017 American College of Surgeons (ACS) verification report identifies that the
Trauma department coordination with the medical center’s Quality department is in need to
improve quality, at the systems-level by reducing VAE as a HAC (ACS, 2017). As a risk
anticipator, the CNL leading this project guide the system level change in the ICU micro-system.
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The CNL from the Trauma department operates in the mesosystem and works as a patient
advocate addressing VAE at the point of care. Coordination of the high-functioning
multidisciplinary team requires focused understanding of the expertise that each team member
brings to solve this multifactorial problem of eliminating VAE in the Level II Trauma Medical
Center.
Knowledge
In the Level II Trauma Center, 96,000 patients receive treatment in 2017. 2,400 of these
patients are Trauma. Out of the 96,000 patients, 117 are attributed to have a diagnosis of VAP.
Of those 117 VAP patients, 93 are medical and 24 trauma patients. The cost to the patient is an
increased risk for morbidity and mortality associated with the HAC. After examining the first
six-months of 2018, there are six patients that developed VAP (CDM, 2018). Despite the slight
decrease of VAP in 2018, the facility is still far from their goal of aim to zero VAP by 2019.
Our goal is to drive the prevalence to zero within the year.
Evidence-based practice shows that the development of biofilm that travels from the
endotracheal tube into the lungs is identified as the source that leads to VAP. The biofilm is the
reservoir for the bacterial to grow, which is encapsulated and makes treatment more complicated
(Levasseur, 2001).
Subglottic Endotracheal tube (SETT)
Endotracheal tube designs have led to the incidence of VAP. The design of endotracheal
tubes, when positioned into the tracheal creates a space that accumulates subglottic secretions
(American Thoracic Society, 2004). The area where these subglottic secretions pool is where that
accumulation of fluid provides a great vector for growing bacteria, which then can migrate down
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the endotracheal tubes. The original design of endotracheal tubes and even tracheostomy tubes is
considered the cause of VAP (Tablan, Anderson, Besser, Bridges, & Hajjeh, 2003). Any device
that leads to the buildup of secretions below the vocal cords, secured in place with a cuff that
holds the airway device in place, is determined the contributing factor for VAP. The area of
pooled secretions provides a direct path of bacteria into the lungs by way of the endotracheal
tubes. Current research from Society of Healthcare Epidemiology of America (SHEA), Center
for Disease Control and Prevention (CDC), and American Thoracic Society recommends SETT
to reduce subglottic secretions in ventilated patients requiring over 48 to 72 hours of intubation
(Klompas, 2015). The benefit of reducing subglottic secretions leads to the multidisciplinary
team approach from clinical experts, with the focus by all is to reduce the environment that
prevents biofilm growth.
Multidisciplinary team
The trauma center’s multidisciplinary team is comprised of trauma surgeons, intensivist
and emergency medicine doctors, and anesthesiologist to represent the physician component of
our team. The nursing component is championed by emergency department (ED), operating
room (OR), and ICU nurses. Department/facility leadership are members to facilitate the
organizational changes at the macrosystem level. The Infection Control and Quality are at the
heart of the team. Each clinical expert is a representative of a larger group of professionals to
work with the multidisciplinary team and hard-wire the utilization of SETT and to improve
performance on the ventilator bundles. The organizational goal is to reduce subglottic secretions
and drive VAP to zero.
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Rationale
Informational interviews are used to gain a clear understanding of what are the
contributing factors that cause VAE (Morris et al., 2011). After a series of interviews, the CNL
develops an Ishikawa diagram displaying the potential causes of a VAE in order to identify its
root causes (see Appendix B). The fishbone diagrams are presented to the Prevent VAE Team;
the team determines that the focus of reducing subglottic secretions is the specific aim for the
phase I of the project. The fishbone demonstrates the relationships between VAE and reduction
of subglottic secretions. The priority is to utilize a SETT for intubation greater than 48 hours
during all ICU admissions (see Appendix B).
The CNL reviews the VAE quality performance bundles, current facility’s policies, and
perform daily nursing practice assessments to identify other causes that contribute to the VAE
events. This is the foundation to prioritize the team plan for action. These findings are
synthesized into a process flow diagram to facilitate a multidisciplinary team discussion about
assignment of responsibilities, how the process should be completed, and how the project will
succeed (see Appendix C).
Having an understanding of the leadership changes at the organization level provides a
clear leadership path for the CNL to affect and impact a change of this size. The structure of the
quality initiative is crucial to develop a culture that will align with the organizational goals to
eliminate VAE. The adoption of the goal to reduce SETT secretions became evident, as the
context of each multidisciplinary team members’ anecdotal remarks led to that same intervention
Identification of the varying aspects that each team represented to decrease subglottic secretions
became the obvious first phase of the project to reduce VAE (Prevent VAE Team, 2018).
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PICOT statement
Patient
The patients included in the Prevent VAE improvement project are all patients in the ICU
who require mechanical ventilation for over 48 hours. Trauma patients are the primary focus due
to the identification of the incidence in the Level II Trauma Centers ACS Report (ACS, 2017).
Problem
The problem occurs when the accumulation of subglottic secretions occur. When there is
not a subglottic suction device present on the endotracheal tube, the ICU patient is more
susceptible to VAE. Untreated VAE can later result in Ventilator Associated Pneumonia.
Intervention
Standardization of the Endotracheal tubes in the ICU that allows subglottic suctioning on
all ICU admitted patients. Revision of the ICU daily rounding flowsheet is to align with VAE
prevention bundles and to prevent inconsistency of practice amongst the multidisciplinary team.
Comparison
The comparison of patients who develop VAE with those patients who are ventilated and
do not develop VAE.
Outcomes
Consistent reduction of subglottic secretions in all ICU ventilated patients and increase
multidisciplinary team VAE bundle compliance to prevent VAP.
Time
The project consist of two phases. Phase 1: From July 1 to July 31, all ICU ventilated
patients will prioritize the use of SETT and the team will assure compliance with the VAE
bundle aimed by the use of the multidisciplinary ICU daily rounding flowsheet (see Appendix
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D). Phase 2: The facility will evaluate the effectiveness of the SETT and facilitate evaluation of
the SETT utilization in the prehospital environment (EMS).
Specific aim
The Prevent VAE Team’s aim is to implement evidence-based practice strategies to
reduce the incidence of VAE. By July 31, 2018, the Level II Trauma Center will revise,
operationalize, and improve the Prevent VAE teams’ bundle compliance by 20%. This will
improve performance of the following evidence-based practice guidelines.
Trauma Surgeons and Intensivists
•

Prioritize utilization of endotracheal tubes with subglottic suctioning (hi-lo tube) to
clear subglottic space. This will include a ICU assessment for switching to the SETT.

•

Monitor daily VAE bundles for compliance.

•

Orders to maintain the head of bed at 30° to 45° angle unless contraindicated.

•

Provide daily sedation vacation to assess patient readiness to wean off of the
ventilator.

•

Provide enteral feedings within 48 hours of intubation.

•

Provide peptic ulcer disease treatment.

•

Provide Deep Venous Thrombosis prophylaxis treatment.

•

Daily intensive care rounds held to evaluate progress, implement early goal-directed
treatment plans, and identify any ventilator associated events.

Nursing
•

Compliance with VAE bundles for evidence-based care.

•

Perform hand hygiene before and after respiratory care.

•

Prioritize maintenance of SETT.
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•

Utilize frequent suctioning, oral care with Chlorhexidine Gluconate twice a day.

•

Communicate progress of spontaneous breathing trial with potential to wean.

•

Facilitate early mobility.
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Respiratory Therapist
•

Maintain VAE bundles of trach cuff pressure of at least 20-centimeter water.

•

Perform hand hygiene before and after any respiratory care.

•

Use disposable ambu-bags that are single patient use only.

•

Use heated wire circuits to provide humidity; do not allow condensation to drain
backwards. Change circuits only when necessary (14 day cycle or when dirty).

•

Participate in frequent suctioning and maintenance of functioning subglottic suction
to endotracheal tubes.
Methods

Context
The utilization of a qualitative convergent-care research (CCR) method determines the
direction and structure of the multidimensional project. The CCR consists of intentional
solutions to a well-known problem, with the introduction of innovative practice improvement
initiatives to accomplish a goal (Stevens, 2013). The process improvement project takes place in
a 34-bed ICU in a Level II Trauma Center. The population consist of ventilated patients in the
ICU setting during the month of July 2018. The project is to refine the multidisciplinary teams’
performance to meet standards of evidence-based care. It was important during the change
process to preserve the autonomy of the high-functioning multidisciplinary team yet maximize
the continuity of the team’s performance toward a common goal.
Ishikawa
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Analysis of the informational interview process demonstrates the promotion of quality
bundle compliance, starting with the assurance of the correct endotracheal tube utilization in the
pre-hospital and OR environments. Both the pre-hospital and the OR areas currently are not
using the SETT. Consequently, not having the SETT, will predispose the ICU patients to
accumulate subglottic secretions, which could lead to a VAP.
The gateway of intubated patients from the pre-hospital setting and the OR are a primary
focus to set the process improvement on track. It is determined that having the SETT in these
areas, will improved compliance with preventative VAE measures.
The informational interviews held by the trauma in the role of a CNL are to analyze
similarly structured open-ended questions format. The team participation, communication and
clarification at the multidisciplinary meetings led to the normalization the CNL biases.
Plan
The data elements are collected between July 1 and July 30, 2018 in two phases. The first
phase included a computerized data pull from data directly entered in the electronic health
record. The development of an integrated database is in use to collect data elements that are
structured by input from the multidisciplinary team. The Director of Quality creates the database.
Additional manual data is collected from the ICU daily rounding form (see Appendix D).
To guarantee reliability, the information from the ICU rounding form is a standardized
answer picklist, of the most common answers, with limited fill-in capacity. The format is created
to standardize the approach. The rounding tool’s design meets compliance to the local medical
center’s critical care team (see Appendix E).

IMPROVE EFFECTIVENESS TO REDUCE VAE

15

Interventions
The initial step of the Prevent VAE team is to review the current Infection Control policy
that describes each part of the VAE quality performance bundle. Through informational
interviews with each discipline’s champions and disruptors alike, their input added into the
design of a cause and effect analysis (Levasseur, 2001). The Ishikawa diagram demonstrated the
strengths and weakness for the prevention of VAE. Coordination and teamwork are determined
to be our process improvement technique.
In a meeting on June 6, 2018, the review of the Ishikawa drawing were analyzed by the
team for input. From there, the team engaged in a deep dive analysis, which unanimously pointed
the multidisciplinary group in the direction of reducing subglottic secretions. Each discipline is a
champion of a multifaceted approach to re-engage their team with top performance goals. The
importance of utilizing a transformational leadership style is to engage the leaders within the
microsystem, to unfreeze their team’s current behaviors, and to prioritize a re-energizing spirit to
adopt this change (Levasseur, 2001).
The members of the Prevent VAE team are challenged with a state of many
organizational changes, competing priorities and transition of upper leadership. The focus is to
drive quality initiatives and improve medical center performance as the mission of the
organization in heading toward a “Highly Reliable Organization” (Beyea, 2012).
An understanding of the benefit to decrease VAE is to improve patient outcomes as the
driving force for the team to be committed to the ventilator bundle compliance. The reduction in
subglottic secretions is tied to ventilator bundle daily performance. The trauma nurse in the role
of the CNL demonstrate the clinical expertise and leadership to navigate the multidisciplinary
team to accomplish these goals.
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The development of a VAE tracking database is championed with the assistance of the
Director of Quality (see Appendix E). The ability to measure and communicate the team’s
results are key to benchmark progress in the program (AACN, 2017).
Operating room change process
One challenge is the introduction of the SETT into the OR. The anesthesia champion
introduces the SETT process in the OR. Intubation of all patients not to be immediately
extubated post-operatively will have the newly identified process utilizing the SETT. The change
in equipment and practice requires education to the OR/anesthesia team. The staff education is
provided on June 17 and June 19, 2018 by the CNL and the OR educator following the project
timeline (see Appendix F). This included four sessions of education with the anesthesiologist on
site. Evidence base articles are provided to reinforce knowledge. The change of SETT takes
place as plan on July 1, 2018. The anesthesia champion engaged any technique questions and
managed all performance measure in association with the utilization of the subglottic
endotracheal tube.
The adaptation to placing the subglottic endotracheal tube is consider minor to address
placement technique. The suggestions for managing the secondary pigtail associated with the
subglottic suction are explained for optimal endotracheal tube placement (see Appendix G). The
OR RN staff are educated on the elements to address connecting the subglottic suction to low
intermittent suction and reassessment during the case to ensure functioning status and no
clogging from thick secretions. Live demonstration, plus hands-on return demonstrations are
utilized to instruct the OR team.
The population of traumatic brain injury patients and trauma patients in extremus are
determined to achieve the most benefit from early placement and evacuation of subglottic
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secretions. On analysis of pre-implementation data, these two cohorts of patients had the highest
incidence of VAE. The initial injury pattern was determined to play a factor in incidental
aspiration at the time of injury/event. Stroke, as well as trauma patients, fell into a similar cohort
of high incidence for VAE, who will benefit from prevention strategies.
Subglottic Endotracheal Tube Equipment
The proper equipment availability is an important factor to the success of the OR
transition to SETT usage and for all in-hospital intubated patients. The endotracheal tube is
standardized in all areas of the medical center, excluding the OR. The in-depth microsystem
assessment involved working with the OR team, including the anesthesia technician, to evaluate
a convenient location to store the subglottic endotracheal tubes for ease in accessibility. Order
information is obtained from the respiratory department leader, and a process is developed to
update the OR ordering form, plus reorganization of the anesthesiologists’ carts to have the
SETT readily available.
All other intubation trays had the SETT as a standard. The intubation tray stocking is
managed by the respiratory therapy department, and they collaborate with OR to facilitate this
long-awaited change in practice. Lewin’s unfreezing process is part of the integration of
evidence-based support to engage the OR team to collaborate in the key aspect of adopting the
use of the SETT (see Appendix G) (Levasseur, 2001).
Model for Improvement
The model for improvement (MFI) is followed for improving the performance with the
ventilator prevention bundles and the focus is to decrease subglottic endotracheal tube secretions.
The MFI is used to implement small tests of change (Nuckton, Holko, McKay, & Newman,

IMPROVE EFFECTIVENESS TO REDUCE VAE

18

2006). Team STEPPS briefing and debriefing was the concept used to support the team’s efforts
to hardwire successive change measures to accomplish a unified goal to reduce VAE to zero.
The first month of this process improvement project is to decrease the subglottic
secretions. The second phase of the project is to introduce early mobilization into the medical
center plan plus integrate the pre-hospital evaluation and training into the equation for success
with VAE reduction. By analyzing the hurdles that are faced by the trauma/medical teams, the
team designed the first phase role out of the project.
Change Strategy
The change strategy of Lewin’s unfreezing previous behaviors is changing to new
subglottic endotracheal tubes and refreezing the improved teamwork and performance strategies
to reduce VAE by 10% within the next month and is the goal of the first phase of the project
(Schriner et al., 2010). The team will focus on ensuring all endotracheal tubes utilize the
subglottic suction to its fullest performance. The nurses’ focus will be on consistent oral care and
daily spontaneous breathing trials, in partnership with respiratory therapy and team
communication on the updated ICU daily rounding flowsheet to navigate and benchmark the
multidisciplinary team’s performance.
Multidisciplinary Team Roles
The interdisciplinary team supervisor/director will be responsible for orienting new staff
to the VAE reduction focus as part of new hire orientation at the Level II Trauma Center. The
unit-specific champions will be responsible for onsite reinforcement for continued success of the
project. Huddles will be used to focus priorities of the team communication and progress.
Communication is the key element. The TeamSTEPPS briefing strategy will be utilized to
provide strategic information to the units for benchmarking progress and motivation for team

IMPROVE EFFECTIVENESS TO REDUCE VAE

19

effort to support improved VAE prevention bundle compliance (Betts & Healy, 2015). Utilizing
the briefing strategy will reinforce the important information. Debriefing will be initiated by the
trauma PI CNL, department leadership, and unit-based champions to drive this process 24 hours
a day, seven days a week, 365 days a year. The communication will focus on engaging the
support of the patient care staff for interactive questions and answers to support the teamwork.
Data
A benchmarking strategic plan will include monthly data distributed on a HACs
dashboard to the ED, OR, and ICU. The data will be compiled from a joint effort of the trauma
database and electronic medical record. An Access database, designed by the medical center’s
director of quality, will be used to demonstrate strategic performance. The complex data analysis
includes monitoring between multiple ventilator days and complex team performance. Analysis
of the process to incorporate all the data elements is essential for the team’s improvement and
benchmarking strength to drive individual, as well as team, performance. The structured database
is designed for growth with each phase of the improvement process. Phase II will include early
mobility metrics, in addition to emergency medical services’ use of subglottic endotracheal tube
placement, to trend improvement and success.
Initial Phase
The initial phase of this two-part project to reduce VAE will be completed by August
2018. Ongoing re-evaluation will be checked each month for the remaining part of 2018. Once
the VAE performance bundle change is stabilized, the re-evaluation plan will be quarterly and
progress reported to the trauma/medical quality review and operation team meetings.
Change Model
The initial step of the Prevent VAE team was to review the current infection control
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policy that describes each part of the quality performance bundle. Through informational
interviews with each discipline’s champions and traditionalist (Stevens, 2013), we designed a
cause and effect analysis of strengths and weakness for our ventilator bundles. Coordination and
teamwork of forming, storming, norming, and performing was determined to be our research
technique (Betts and Healy, 2015). In a meeting on June 6, 2018, we reviewed the Ischikawa
drawing of the team’s input. From there, we engaged in a deep dive analysis, which unanimously
pointed the multidisciplinary team in the direction of reducing subglottic secretions. Each
discipline championed a three-pronged approach to re-engage their team with top performance
goals. Transformational leadership engaged the microsystem to unfreeze the current behavior to
prioritize an improvement culture. The importance of the trauma PI CNL to utilize a
transformational leadership style to engage each of the VAE disciplinary leaders was the
important skill to unfreeze the current behaviors. Reprioritization and re-energizing the spirit to
adopt the Prevent VAE change was the initial goal. This is an important problem, with the goal
of improving outcomes for the ventilated ICU patients. The members of the Prevent VAE
multidisciplinary team were challenged with many competing priorities within the organization,
in addition to a change in leadership. The focus was to drive quality initiatives and improve
medical center performance, so this was a common goal for the ICU department, the trauma
department, and the macro system (Viana, Bragazzi, Couto de Castro, Alves, & Rocco, 2013).
The clear understanding of complexities plus multivariate factors with each ventilated patient
was the multidisciplinary team’s motivation to drive their initiative in a competitive spirit (Viana
et al., 2013). Understanding the benefit of decreasing VAEs and improving patient outcomes led
to the team’s commitment to the ventilator bundle compliance of decreasing subglottic
secretions. The trauma process improvement RN, working as a clinical expert and leader, and
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navigated the multidisciplinary team and developed a database, with the assistance of the quality
liaison director, to measure and communicate the team’s results.
Lewin’s Change Strategy
One challenge is the introduction of the subglottic endotracheal tube into the OR. The OR
staff are very structured and rigid to new changes creating a more traditionalist view of change
(Schriner et al., 2010). The subglottic endotracheal tube introduction will bring new challenges
for the team. The anesthesia champion introduced the change in process to intubate all patients
that will not be immediately extubated post-op with the subglottic endotracheal tube. The change
in equipment and practice required education for the OR/anesthesia team. On June 7, the OR was
educated by the trauma PI CNL and the OR educator. This included four sessions of education
that included the anesthesiologist on site. A plan for the change to be initiated July 1, 2018, with
evidence-based literature articles, was sent the anesthesia team. The anesthesia champion
engaged any technique questions and managed all performance measure in association to the
utilization of the subglottic endotracheal tube. The adaptation to placing the subglottic
endotracheal tube is considered minor in addressing placement technique with suggestions for
managing the secondary pigtail associated with the subglottic endotracheal tube. The OR RN
staff was educated on the elements to address connecting the subglottic suction to low
intermittent suction and reassessment during the case to ensure functioning status and no
clogging from thick secretions.
Population
The population of traumatic brain injury patients and trauma patients in extremus were
determined to achieve the most benefit from early placement and evacuation of subglottic
secretions. On analysis of pre-implementation data, these two cohorts of patients had the highest
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incidence of VAE. The initial injury pattern was determined to play a factor in incidental
aspiration at the time of injury/event. Stroke patients, as well, fell into a similar cohort of high
incidence for VAE prevention strategies.
This equipment availability is an important factor to the success of the transition to
subglottic endotracheal tube usage for all in hospital-intubated patients. The endotracheal tube is
standardized in all areas, excluding the OR. The in-depth microsystem assessment involved
working with the OR team, including the anesthesia technician, to evaluate a convenient location
to store the subglottic endotracheal tube for ease in accessibility. Order information was obtained
from the respiratory department leader and a process developed to update the OR ordering form
and reorganize the anesthesiologist’s carts to have the subglottic endotracheal tube readily
available. All other intubation trays had the subglottic endotracheal tubes as a standard. The
respiratory therapy department manages the intubation tray stocking, and they collaborate with
OR to facilitate this long-awaited change in practice.
TeamSTEPPS
The MFI was the strategy followed for improving performance with the ventilator
prevention bundles and the focus to decrease subglottic endotracheal tube secretions. The MFI
will be used to implement small tests of change (Nuckton et al., 2006). Team STEPPS briefing
and debriefing will be used to support the team’s efforts to hardwire successive change measures
to accomplish a unified goal to reduce ventilator associated events to zero. The first month of
this process improvement project was to decrease the subglottic secretions. The second phase of
the project is to introduce early mobilization into the equation for success with VAE reduction.
After analyzing the hurdles faced by the trauma/medical teams, we designed the first phase role
out of the project.
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Change Strategy
The change strategy of Lewin’s unfreezing previous behaviors and refreezing the
improved teamwork and performance strategies to reduce VAE by 10% in the following month
(Schriner et al., 2010). The team will focus on ensuring all endotracheal tubes utilize the
subglottic suction to its fullest performance. The nurses will focus on consistent oral care, daily
spontaneous breathing trials in partnership with respiratory therapy, and team communication on
the updated ICU daily rounding flowsheet to navigate and benchmark the multidisciplinary
team’s performance.
Multidisciplinary Team Roles
The multidisciplinary team supervisor/director will be responsible for orienting new staff
to the VAE reduction project as part of new hire orientation at the Level II Trauma Center. The
unit-specific champions will be responsible for onsite reinforcement for continued success of the
project. Huddles is used to focus priorities of the team communication and progress. The
TeamSTEPPS briefing strategy is utilized to provide strategic information to the units for
benchmarking progress and motivation for team effort to support improved VAE prevention
bundle compliance. Utilizing the briefing strategy will reinforce the important information
(Tibbs & Moss, 2014). Debriefing will be initiated by the trauma CNL, department leadership,
and unit-based champions to drive this process, 24 hours a day, seven days a week, and 365 days
a year. Communication will focus on engaging the support of the patient care staff for interactive
questions and answers and to support the teamwork.

IMPROVE EFFECTIVENESS TO REDUCE VAE

24

Benchmark
A benchmarking strategic plan will include monthly data distributed on a HAC dashboard
to each corresponding department team. The data is compiled from a joint effort of the trauma
database and the electronic health record. An Access database provides additional information
and is designed by the facility Director of Quality to demonstrate strategic performance.
The complex data analysis includes monitoring between multiple ventilator days and
complex team performance. Analysis of the process to incorporate all the data elements is
essential for the team’s improvement and benchmarking strength to drive individual
performance, as well as team performance. The structured database is designed for growth with
each phase of the improvement process. Phase II will include early mobility metrics to trend for
improvement and success.
The initial phase of this two-part project to reduce VAE is to be completed by August
2018 (Appendix F). Ongoing re-evaluation will be checked each month for the remainder of
2018. Once the VAE performance bundle change is stabilized, the re-evaluation plan will be
quarterly and the progress is reported to the trauma/medical quality review and operation team
meetings.
Study of the Intervention
The intervention strategy that the Prevent VAE team agreed to use is to improve
performance on the VAE bundle compliance. A bundle is a structured way of improving the
processes of care and patient outcomes—a small, straightforward set of evidence-based practices
(Nuckton et al., 2006). The Prevent VAE team realizes that evaluating and improving team
performance on the evidence-based practice guidelines is the foundation of the ICU Prevent
VAE’s improvement project. The Prevent VAE team analyzed their respective team’s consistent
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performance of the prevention bundles and realized that key opportunities to provide consistent
bundle delivery are the foundation of the project. The data analysis from retrospective chart
review brought new perspective to system issues that prevented optimal performance for VAE
prevention bundle compliance. The Prevent VAE team identifies that the ICU rounding tool is an
ideal structure to communicate and trend the required data elements for the aim to zero ventilator
compliance strategy. Teamwork is the focus of the daily multidisciplinary rounding, and the tool
is a useful way to share on-time information, adjust performance, and drive success for VAE
prevention. The Prevent VAE ‘s champions revised the ICU rounding form to add key elements
to track subglottic endotracheal tube usage. The ability to provide real-time feedback to
anesthesia for prioritizing subglottic endotracheal tube utilization for patients who would require
ongoing intubation in the ICU setting is valuable for debriefing about any variance in the
process. The real-time feedback allows debriefing and planning to look at any variation in
process. The trauma surgeons/intensivist that lead the ICU rounds provides the opportunity to
drive the SETT exchange as a patient is stabilized. The standard endotracheal tubes are
prioritized to be exchanged for SETT at this time. The daily goal of decreasing subglottic
secretions, plus VAE prevention progress, are tracked and reinforced by the VAE champions to
increase compliance with decreasing subglottic secretions.
Cohort Comparison
Cohort comparison case review led the team to determine that SETT introduction into the
OR setting is heading in the direction to integrate the process of decreasing subglottic secretions.
The new OR director joined the Prevent VAE team in progress of implementation. The
anesthesiologist placement of the SETT is similar enough to the standard endotracheal tube
placement so there is not a need for additional training (see Appendix G). Although this is the
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overall pre-implementation thought process, the anesthesia team is supported by the anesthesia
director, for performance evaluation and support for education. The team support is to place the
subglottic endotracheal tubes for those patients requiring ongoing intubation into the ICU setting.
The anesthesia director and the OR educator partnered with real-time feedback to those cases
identified by the trauma CNL in the role of risk anticipator, to position the team for success by
reinforcing the Prevent VAE team’s strategic goals (AACN, 2017).
Operating Room Change
The OR is an extremely important area identified by the team for standardizing the use of
SETT throughout the medical center. All other medical areas, including ED, ICU, rapid response
team (RRT), and code carts, are stocked with only SETT. This identified area for process
improvement is managed by the coordination of the Prevent VAE team’s ability to share
evidence-based practice information. The supporting studies from CDC, SHEA, and American
Thoracic Society are used to unfreeze the traditionalists and create the awareness for
disseminating information (Levasseur, 2001). The focus is designed to support the awareness
required to motivate the change process. The OR integration is the first strategic step toward
Level II Trauma Center endotracheal tube standardization to attack subglottic secretions.
Pre-Hospital Evaluation
Case review inquiry led the Prevent VAE team to analyze the organization for other ports
of entry for standard endotracheal tubes. The identification of this fact led to the practice of
standard endotracheal tubes being placed in the pre-hospital setting as the next phase on our
mission to reduce subglottic secretions in ventilated patients. The field represents the area where
injury patterns of decreased neurological status, proven from trauma, stroke, or shock,
predisposed those patient populations for incidental aspiration. In order to manage the secretions
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trapped in the trachea, the SETT is the ideal solution to combat the problem. Phase II of the
Prevent VAE project includes the EMS providers’ medical director, to perform a subglottic
endotracheal tube evaluation. The SETT representative is in contact, and the initial educational
process is scheduled in August 2018 for introduction of the new product into the EMS provider
system. The trauma CNL will analyze data from trauma case review to drive process
improvement change throughout the trauma mesosystem. Continuous trauma case review and
process improvement will be driven by the ACS initiative to support evidence-based care
nationwide.
Measures
Both quantitative and qualitative measures are in use to analyze data to evaluate the
Prevent VAE measures, with the aim for zero improvement project. The data extracted will be
derived from patient cohort identification, admission diagnosis, medical history, calculations of
ventilator days and titration of ventilator settings of FIO2 and PEEP, type of endotracheal tube,
percent of functioning subglottic suction, percent of oral care, and number of bronchoscopies in
relation to the outcome measures of number of VAE to ventilated patients for the month of July
2018 (see Appendix E). During the month of July, there are three VAE for 48 ventilated patients.
There are 39 SETT in ICU versus seven standard endotracheal tubes. There are 98.7% of the
ESTT originated from the ED. The ED has been utilizing SETT for the past two years. More data
will need to be attained to determine the success in the OR integration of the SETT. There are
three endotracheal tubes placed in the pre-hospital setting and two in the OR. The use of SETT is
the main element being evaluated in the Prevent VAE improvement process. Although the team
does not see many originating from the OR, eight patients is transferred from ED to the OR
already intubated. The data shows that only three VAE occurs in July, with one patient having
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two episodes of VAE. This marks the progress of Phase I of the Prevent VAE project. No trauma
patients with VAE for the past two months are identified.
Quantitative measures include the number of SETT used in comparison to the routine
endotracheal tube during July. The 98.7% utilization of SETT is attributed to the decrease in
incidence of VAE. Each month, the number of SETT are tracked in order to hardwire the
progress of the Prevent VAE team. The data analysis and communication will be used to guide
the aim of the project to reduce VAE to zero by December of 2019. The trauma center locations
where endotracheal tubes are placed will be tracked to delineate future Prevent VAE project
phasing. This factor is identified from the results of Phase I analysis and leads to the Phase II
pre-hospital subglottic endotracheal tube evaluation.
The qualitative evaluation of the cohort case reviews, and the data from the ICU daily
rounding flowsheet, are what attributes VAE prevention bundle effectiveness that are used to
decrease subglottic secretions; as the means of data. The qualitative tool used to evaluate the
progress of the multidisciplinary Prevent VAE team’s ability to meet their goal still requires
some improvement. The ability to increase the Prevent VAE bundle compliance is directly tied
to the reduction in subglottic secretions by the functioning of the subglottic suction system, oral
care bundles, and increased mobility; this information is difficult to track.
The effectiveness of ICU rounding, which has VAE performance measures integrated
into them, provides improved team coordination of information for real-time continuous quality
improvement (Nuckton et al., 2006). The ICU tool is in revision again to add additional ICU
elements into the daily rounds. The increased awareness of the improvement project with the
daily rounding helped maintain the Prevent VAE team’s goals, despite the pitfalls of the tool. The
team identified that there is a need to have a new rollout plan as the project moves forward.
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Shared Initiative
The development of the Access database to compile the VAE results is a shared
organization initiative to integrate the trauma improvement team, collaborating with the quality
department, to drive mesosystem change. VAE is a reportable quality metric and an ACS focus
to integrate performance measures across the continuum of the entire mesosytem (ACS, 2017).
The multidisciplinary Prevent VAE team provides the Level II Trauma Center a beneficial forum
to achieve quality success and improve patient outcomes. Although a majority of the ESTT are
placed in the ED, utilizing it demonstrates the reduction in VAE during the month of July.
Ethical Consideration
Patient advocacy to protect the vulnerable is the number one ethical consideration for the
Prevent VAE team. Advocacy is the CNL role that is at the center of all considerations for the
multidisciplinary team. From the physiological requirement for ventilator support to the
endotracheal tube exchange, the clinical decisions for the patient involve the analysis for risk and
improved patient outcomes. Timing to predict when benefit will outweigh risk is attributed to
every medical provider’s decision to exchange an endotracheal tube. Physiological stability is
always the qualitative measure to clearly make the endotracheal tube exchange decision.
Autonomy
Support for autonomy is an ongoing requirement for evaluating ventilator support in
consideration to improve patient outcomes. When the patient is unable to actively participate or
communicate their wishes, the family is able to follow what the patient has previously decided
for themselves (Mehndiratta et al., 2016).
Through the multidisciplinary Prevent VAE team’s evaluation, the decision to add early
mobility into the VAE bundle compliance is unanimously determined as the next phase of the
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process improvement. The culture for engaging frontline staff into continuous quality
improvement is infectious in a positive nature. The autonomy and strength to incorporate
ambulation inspires benefit to patients, their families, the entire multidisciplinary team, and the
whole culture of the microsystem (Mendez-Tellez & Needham, 2012).
Outcome Measures Results
The effect that the implementation of decreasing subglottic secretions by implementing
ICU daily rounding flowsheet to coordinate VAE prevention bundle compliance attributes
qualitative measures to review the process improvement results. The trauma CNL reviews and
analyzes all qualitative data. The standardization of clinical definitions are attribute by the CDC
definitions for VAP. Variation of clinical biases is controlled by navigating fill-in responses to
the most common information available from chart review prior to program implementation.
Database
The Access database developed by the quality director integrated computerized generated
input directly from the electronic health record. The ability to present clear data is strength of the
Prevent VAE team’s benchmarking abilities. The collaboration of the quality department and
trauma to work together to achieve a reduction in the most costly HAC in the organization
demonstrated a new partnership for the organization.
Analysis
Prevent VAE project analysis demonstrated a 98.7% utilization of SETT in July 2018.
The 39 SETT per 46 ventilated patients attributed to the number of SETT used in the ICU. There
are no endotracheal tubes exchanged by the intensivists in the ICU for the month of July 2018.
Reinforcement for the Prevent VAE project’s goal is to utilize SETT for ventilated patients over
48 hours was 80% for the month of July. The team will need to continue to educate and reinforce
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the utilization of SETT.
Summary
By instituting the use of SETT in the OR, the facility standardize endotracheal tubes
and work as the foundational process to decrease subglottic secretions as the vector that
contributes to VAE at the Level II Trauma Center. The goal of a 10% reduction is
achieved during Phase I of the project. The addition of incorporating the progress of the
multidisciplinary team to attack the problem of VAE and improve quality bundle
performance compliance is the largest contributing factor for the process improvement.
The cost of a the subglottic endotracheal tube is $3.00 more than the standard endotracheal
tube. The cost of one VAE is conservatively estimated to be $21,500 per diagnosis
(Charge master, 2017). On average, each VAE demonstrates a 1.5 to 9 day increase in
length-of-stay in the ICU (Bekaert et al., 2011). The Prevent VAE team designed a
practical approach to reducing VAE. The Prevent VAE team’s clinical expertise
motivated the compliance of the frontline staff to guide the successes. The integration of
the ICU rounding tool into delineating team progress and navigation is strategic to the
improvement process. The ICU multidisciplinary rounding will be integral to the Prevent
VAE communication and adaptation. Variations in practice can be identified and either
corrected or adopted to evaluate for future best practice evaluation.
The Prevent VAE team learned that they could improve team performance more quickly
working together on the same goal versus independently to achieve a common goal. Teamwork
was the unifying structure that resonated the success of the aim to drive VAE to zero. The depth
of clinical expertise in the multidisciplinary team and in the leadership in daily ICU rounding
empowered the frontline staff to own and share in the pride of the performance on the Prevent
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VAE clinical performance bundles to achieve improved outcomes for the ICU patients and their
families.
The Prevent VAE team interpreted the OR change as a success at the mesosystem level.
Identification of the EMS recommendation to utilize subglottic endotracheal tubes for all
emergent intubations will present a new phase to continue the opportunity to decrease VAE, and
plans to pursue the county evaluations. Analysis of this study is a contributing factor to
demonstrate that utilization of SETT and teamwork to clear subglottic secretions as the best
practice standard. This process requires further evaluation throughout the county system for
possible adoption nationwide.
Limitations
The Prevent VAE team’s limitations are a multitude of competing clinical priorities. In
analysis of the clinical data, the Prevent VAE team evaluated the patient acuity and timing of
consistent oral care. The hurdles of team compliance factors attributed to the availability of
supplies is addressed by increasing oral care kits in the ICU, especially on weekends and
holidays. Noted variation is attributed to the factor of accessibility of oral care with
chlorhexidine. Consistency in the bundle compliance of oral care is focused as part of the bundle
compliance for nursing. Suction regulator accessibility in the OR and the ICU became a factor of
increased utilization of SETT. Department leadership identified a standard room set-up that
included an additional suction regulator for SETT suction. Teamwork with frontline staff and
department leadership attributed to the success of this on-going priority for consistent successful
bundle compliance. Sustainability will be supported by evaluation at the ICU/trauma Quality
Review (QRC) Committee meetings. Plans for the Prevent VAE team’s ongoing needs will be
prioritized at the QRC meetings, and ongoing loop closure measures will be placed into the
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department performance dashboards.
Conclusion
In order to achieve the goal of driving VAE to zero in the ICU at the Level II Trauma
Center, the development of a multidisciplinary Prevent VAE team is created. The combination of
clinical expertise and champion mentoring, real-time debriefing, and coordination of progress
with the daily ICU rounding supported the multidisciplinary team bundle compliance to reduce
VAE (Tibbs & Moss, 2014). The implementation of this project is reproducible. Evidence-based
bundle compliance is the standard of care. Transparency in the hurdles to optimal
multidisciplinary team performance led the required system changes to support the bundle
compliance. Teamwork with the response to the identified common goal to reduce VAE is
integral to adoption and project success. Integration of the ICU rounding tool to navigate the
project progress and to continue the support, is attributed to the success to reduce VAE at the
Level II Trauma Center. The ICU team leadership includes intensivist, trauma, OR, nursing, and
respiratory peer champions, who all collaborate to engage the staff with real-time support. The
implications for practice are in utilizing the MFI change theory, with small test of change to
allow the Prevent VAE project to adapt in real time to support the improved patient outcomes.
Clinical Nurse Leader Role
In the position of the trauma process improvement CNL, the role of continuous quality
improvement is the expectation for the role. Trauma patients are assessed and data analyzed from
the trauma database (CDM, 2018). The role of the CNL is to integrate systems level change from
the point of care (AACN, 2017). The role is integrated into each phase of the improvement
process. The CNL, as a leader, works as a horizontal member of the multidisciplinary team to
coordinate systems level change and improve patient outcomes. Utilizing Tuckman’s
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teambuilding strategies, the CNL utilized data to encourage team participation and call to action
to conquer the clinical problem of the HAC VAE.
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Appendix A
Ventilator-Associated Events (VAE) Surveillance Algorithm

Note: Retrieved from CDC Algorithm for Ventilator – Associated Events, January 2018.
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Appendix B
Ishikawa Diagrams VAE Prevention: Cause & Effect Global Factors

Ishikawa Diagrams VAE Prevention: Cause & Effect Specific AIM

Note: Multidimensional factors identified for Prevent VAE Team prioritization to
decrease incidence of subglottic secretions
Created by Ginger Miramontes June, 2018
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Appendix C
Decision Flow Chart for Subglottic Endotracheal Tube Process

Note: Created by Ginger Miramontes RN-Trauma Process Improvement (PI)
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Appendix D
Daily ICU Rounding Tool

Note: Briefing tool integrating VAE tracking elements by Ginger Miramontes RN
Trauma Process Improvement (PI)
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Appendix E
Project Specific Database

Ben Yind Siu-James MD, MSCIS Director of Clinical Analytics Quality Department

Note: Screen shots of new database. Developed for project specific data collection and analysis.
Data retrieved from Regional Medical Center of San Jose facility’s Quality Department Created
by Director of Quality Services to support the Prevent VAE Team on July 31, 2018.
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Appendix F
Prevent VAE Timeline

Note: Timeline for Prevent VAE Improvement Project Phase I
Created by Ginger Miramontes RN
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Appendix G
Pictorial- Rational for Utilization of Subglottic Endotracheal Tube

Note: Adapted from (Muscedere, 2011) Rational for Utilization of Subglottic ETT to clear
subglottic secretions
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Appendix H
Level II Trauma Center

Data retrieved from Regional Medical Center of San Jose facility’s Quality Department Created
by Director of Quality Services to support the Prevent VAE Team on July 31, 2018.
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Appendix I
Level II Trauma Center

Data retrieved from Regional Medical Center of San Jose facility’s Quality Department Created
by Director of Quality Services to support the Prevent VAE Team on July 31, 2018.

